Q2 2016 Holdings
Filed 2016-08-10 | 23 holdings | $1.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Intrexon Corp | COM | 46122T102 | $1.5M | 61,904,943 | 79.4% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $166.6K | 19,305,403 | 8.7% |
| Ziopharm Oncology Inc | COM | 98973P101 | $53.2K | 9,692,403 | 2.8% |
| Avexis Inc | COM | 05366U100 | $44.7K | 1,176,863 | 2.3% |
| Enterprise Prods Partners L(EPD) | COM | 293792107 | $30.3K | 1,035,834 | 1.6% |
| Synthetic Biologics Inc | COM | 87164U102 | $23.8K | 13,238,268 | 1.2% |
| Fibrocell Science Inc | COM NEW | 315721209 | $19.1K | 16,620,414 | 1.0% |
| Energy Transfer Equity L P(ET) | COM UT LTD PTN | 29273V100 | $10.8K | 752,400 | 0.6% |
| Genesis Energy L P(GEL) | UNIT LTD PARTN | 371927104 | $8.3K | 217,000 | 0.4% |
| Oragenics Inc | COM NEW | 684023203 | $7.9K | 15,481,644 | 0.4% |
| Nustar Energy LP | UNIT COM | 67058H102 | $5.8K | 116,500 | 0.3% |
| TC Pipelines LP | UT COM LTD PRT | 87233Q108 | $5.6K | 97,000 | 0.3% |
| Histogenics Corp | COM | 43358V109 | $4.6K | 2,690,570 | 0.2% |
| Transgenomic Inc | COM NEW | 89365K305 | $4.2K | 7,550,669 | 0.2% |
| Martin Midstream Prtnrs L P(MMLP) | UNIT L P INT | 573331105 | $3.3K | 141,800 | 0.2% |
| Energy Transfer Prtnrs L P | UNIT LTD PARTN | 29273R109 | $3.2K | 85,135 | 0.2% |
| Ovascience Inc | COM | 69014Q101 | $1.9K | 373,224 | 0.1% |
| Ampliphi Biosciences Corp | COM NEW | 03211P202 | $1.8K | 1,158,788 | 0.1% |